Document is current
Any future updates will be listed below
-
Authors
Lilly, Marie V. https://orcid.org/0000-0001-9471-4108
Davis, Myles
Kross, Sara M. https://orcid.org/0000-0002-5650-5839
Konowal, Christopher R.
Gullery, Robert https://orcid.org/0009-0009-8347-3236
Lee, Sung-Joo https://orcid.org/0000-0003-0745-258X
Poulos, Katherine I. https://orcid.org/0009-0008-5768-6265
Gregory, Nichar https://orcid.org/0000-0002-0872-9950
Nagy, Christopher https://orcid.org/0000-0002-2835-2150
Cozens, Duncan W.
Brackney, Doug E. https://orcid.org/0000-0002-6486-3134
del Pilar Fernandez, Maria https://orcid.org/0000-0001-8645-2267
Diuk-Wasser, Maria https://orcid.org/0000-0001-8809-3050
-
Funding
Funding for this research was provided by:
National Science Foundation (10328000)
National Science Foundation (1924061)
National Science Foundation (1924061)
Valneva and Pfizer
Centers for Disease Control and Prevention and Northeast Regional Center for Excellence in Vector Borne Diseases (U01CK000509-0)
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 11 April 2025
First Online: 22 April 2025
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
